Ordenar

Buscar

01/05/2022 Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases
Bullich G., Matalonga L., Pujadas M., Papakonstantinou A., Piscia D., Tonda R., Artuch R., Gallano P., Garrabou G., González J.R., Grinberg D., Guitart M., Laurie S., Lázaro C., Luengo C., Martí R., Milà M., Ovelleiro D., Parra G., Pujol A., Tizzano E., Macaya A., Palau F., Ribes A., Pérez-Jurado L.A., Beltran S., Schlüter A., Rodriguez-Palmero A., Cáceres A., Nascimento A., García-Cazorla À., Cueto-González A., Marcé-Grau A., Nel.lo A.R., Martínez-Monseny A., Sànchez A., García B., Pérez-Dueñas B., Gel B., Fusté B., Hernández-Ferrer C., Casasnovas C., Ortez C., Arjona C., Hernando-Davalillo C., de Benito D.N., Amador D.P., Gómez-Andrés D., Yubero D., Pelegrí-Sisó D., Verdura E., García-Arumí E., Castellanos E., Gabau E., Tobías E., López-Grondona F., Cardellach F., Garcia-Garcia F.J., Munell F., Tort F., Aznar G., Olivé-Cirera G., Tell G., Muñoz-Pujol G., Paramonov I., Blanco I., Madrigal I., Valenzuela I., Gut I., Cusco I., Trotta J.-R., Cruz J., Díaz-Manera J., Milisenda J.C., Ma Grau J., Garcia-Villoria J., Armstrong J., Cantó J., Sala-Coromina J., Rodríguez-Revenga L., Alias L., Gort L., González-Quereda L., Costa M., Fernández-Callejo M., López-Sánchez M., Álvarez-Mora M.I., Gut M., Serrano M., Raspall-Chaure M., Toro M.D., Bayés M., Díez N.B., Spataro N., Capdevila N., Ugarteburu O., Muñoz-Cabello P., Duque P.R., Rabionet R., Rojas-García R., Calvo R., Urreizti R., Bernal S., Boronat S., Balcells S., Vendrell T.. Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases. JOURNAL OF MOLECULAR DIAGNOSTICS. 2022; 24(5)DOI:10.1016/j.jmoldx.2022.02.003. PMID:35569879. IF:4.100(Q2/3D).
01/05/2022 Digital PET vs Analog PET: Clinical Implications?
López-Mora D.A., Carrió I., Flotats A.. Digital PET vs Analog PET: Clinical Implications?. SEMINARS IN NUCLEAR MEDICINE. 2022; 52(3)DOI:10.1053/j.semnuclmed.2021.10.004. PMID:34836617. IF:4.900(Q1/2D).
01/05/2022 The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?
Lopez-Delgado, JC, Grau-Carmona, T, Trujillano-Cabello, J, Garcia-Fuentes, C, Mor-Marco, E, Bordeje-Laguna, ML, Portugal-Rodriguez, E, Lorencio-Cardenas, C, Vera-Artazcoz, P, Macaya-Redin, L, Martinez-Carmona, JF, Mateu-Campos, L, Gero-Escapa, M, Gastaldo-Simeon, R, Vila-Garcia, B, Flordelis-Lasierra, JL, Montejo-Gonzalez, JC, Servia-Goixart, L. The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?. Nutrients. 2022; 14(9)DOI:10.3390/nu14091904. PMID:35565870. IF:5.900(Q1/2D).
01/05/2022 Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain
Moreno-Martinez, E, de la Serna-Torroba, J, Escudero-Vilaplana, V, Hernandez-Rivas, JA, Sanchez-Cuervos, M, Sanchez-Hernandez, R. Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain. Farmacia Hospitalaria. 2022; 46(3)DOI:10.7399/fh.11829. PMID:36183205. IF:(Q/D).